ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results - FOX 54 WZDX – Huntsville News, Weather and Sports

ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ANI Pharmaceuticals

BAUDETTE, Minn., April 28, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2014 financial results on Monday, May 5, 2014, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website, www.anipharmaceuticals.com.

Arthur Przybyl, President and Chief Executive Officer, and Charlotte Arnold, Chief Financial Officer, also plan to host a conference call to review those results starting at 10:30am, Eastern Time on May 5, 2014. The call will be open to the public and can be accessed through a conference line by dialing (855) 582-8078. The conference ID is 33864960.

A recording of the conference call will be available within two hours of the completion of the call and will remain accessible for a period of seven days following the call. To access the replay, dial (855) 859-2056. The access code for the replay is 33864960.

About ANI

ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com.

For more information about ANI, please contact:
Arthur S. Przybyl
(218) 634-3608
arthur.przybyl@anipharmaceuticals.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow